Literature DB >> 22544741

ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditions.

Dorothee Fried1, Beate B Böhm, Kristin Krause, Harald Burkhardt.   

Abstract

ADAM15, a disintegrin and metalloproteinase, is capable of counteracting genotoxic stress-induced apoptosis by the suppression of caspase-3 activation. A cell line expressing the membrane-bound ADAM15 without its cytoplasmic tail, however, lost this anti-apoptotic property, suggesting a crucial role of the intracellular domain as a scaffold for recruitment of survival signal-transducing kinases. Accordingly, an enhanced phosphorylation of FAK at Tyr-397, Tyr-576, and Tyr-861 was detected upon genotoxic stress by camptothecin in ADAM15-transfected T/C28a4 cells, but not in transfectants expressing an ADAM15 mutant without the cytoplasmic tail. Accordingly, a specific binding of the cytoplasmic ADAM15 domain to the C terminus of FAK could be shown by mammalian two-hybrid, pulldown, and far Western studies. In cells expressing full-length ADAM15, a concomitant activation of Src at Tyr-416 was detected upon camptothecin exposure. Cells transfected with a chimeric construct consisting of the extracellular IL-2 receptor α-chain and the cytoplasmic ADAM15 domain were IL-2-stimulated to prove that the ADAM15 tail can transduce a percepted extracellular signal to enhance FAK and Src phosphorylation. Our studies further demonstrate Src binding to FAK but not a direct Src interaction with ADAM15, suggesting FAK as a critical intracellular adaptor for ADAM15-dependent enhancement of FAK/Src activation. Moreover, the apoptosis induction elicited by specific inhibitors (PP2, FAK 14 inhibitor) of FAK/Src signaling was significantly reduced by ADAM15 expression. The newly uncovered counter-regulatory response to genotoxic stress in a chondrocytic survival pathway is potentially also relevant to apoptosis resistance in neoplastic growth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544741      PMCID: PMC3375543          DOI: 10.1074/jbc.M112.347120

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  ADAMs: key components in EGFR signalling and development.

Authors:  Carl P Blobel
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

2.  Lack of ADAM15 in mice is associated with increased osteoblast function and bone mass.

Authors:  Marilena Marzia; Victor Guaiquil; William C Horne; Carl P Blobel; Roland Baron; Riccardo Chiusaroli
Journal:  Biol Chem       Date:  2011-07-30       Impact factor: 4.700

3.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

Authors:  Vita M Golubovskaya; Carl Nyberg; Min Zheng; Frederick Kweh; Andrew Magis; David Ostrov; William G Cance
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

4.  Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins.

Authors:  Iivari Kleino; Rebekka M Ortiz; Miljamartta Yritys; Ari-Pekka J Huovila; Kalle Saksela
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

5.  Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis--structure, chaos and senescence.

Authors:  Thomas Aigner; Stefan Söder; Pia M Gebhard; Audrey McAlinden; Jochen Haag
Journal:  Nat Clin Pract Rheumatol       Date:  2007-07

6.  Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein.

Authors:  Elena Kurenova; Li-Hui Xu; Xihui Yang; Albert S Baldwin; Rolf J Craven; Steven K Hanks; Zheng-Gang Liu; William G Cance
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.

Authors:  M B Goldring; J R Birkhead; L F Suen; R Yamin; S Mizuno; J Glowacki; J L Arbiser; J F Apperley
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells.

Authors:  D Nath; P M Slocombe; P E Stephens; A Warn; G R Hutchinson; K M Yamada; A J Docherty; G Murphy
Journal:  J Cell Sci       Date:  1999-02       Impact factor: 5.285

9.  ADAM15 gene structure and differential alternative exon use in human tissues.

Authors:  Iivari Kleino; Rebekka M Ortiz; Ari-Pekka J Huovila
Journal:  BMC Mol Biol       Date:  2007-10-15       Impact factor: 2.946

10.  Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma.

Authors:  Julia L Zhong; Zaruhi Poghosyan; Caroline J Pennington; Xanthe Scott; Madeleine M Handsley; Alba Warn; Jelena Gavrilovic; Katja Honert; Achim Krüger; Paul N Span; Fred C G J Sweep; Dylan R Edwards
Journal:  Mol Cancer Res       Date:  2008-02-22       Impact factor: 5.852

View more
  5 in total

1.  Maintenance of Proper Germline Stem Cell Number Requires Adipocyte Collagen in Adult Drosophila Females.

Authors:  Lesley N Weaver; Daniela Drummond-Barbosa
Journal:  Genetics       Date:  2018-06-08       Impact factor: 4.562

2.  Preferred SH3 domain partners of ADAM metalloproteases include shared and ADAM-specific SH3 interactions.

Authors:  Iivari Kleino; Annika Järviluoma; Jussi Hepojoki; Ari Pekka Huovila; Kalle Saksela
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

3.  Cell adhesion-induced transient interaction of ADAM15 with poly(A) binding protein at the cell membrane colocalizes with mRNA translation.

Authors:  Beate B Böhm; Yuliya Fehrl; Tomasz Janczi; Nadine Schneider; Harald Burkhardt
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

4.  A Novel Pro-Inflammatory Mechanosensing Pathway Orchestrated by the Disintegrin Metalloproteinase ADAM15 in Synovial Fibroblasts.

Authors:  Tomasz Janczi; Florian Meier; Yuliya Fehrl; Raimund W Kinne; Beate Böhm; Harald Burkhardt
Journal:  Cells       Date:  2021-10-09       Impact factor: 6.600

5.  ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.

Authors:  Guadalupe Lorenzatti Hiles; Amanda Bucheit; John R Rubin; Alexandra Hayward; Angelica L Cates; Kathleen C Day; Layla El-Sawy; L Priya Kunju; Stephanie Daignault; Cheryl T Lee; Monica Liebert; Maha Hussain; Mark L Day
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.